Climatological and Geographical Impacts on the Global Pandemic of Influenza A (H1N1) 2009

2014 ◽  
pp. 233-248 ◽  
Author(s):  
Bing Xu ◽  
Zhenyu Jin ◽  
Zhiben Jiang ◽  
Jianping Guo ◽  
Michael Timberlake ◽  
...  
Keyword(s):  
Influenza A ◽  
Global Pandemic ◽  
Influenza A H1n1

scholarly journals Progression and Trends in Virus from Influenza A to COVID-19: An Overview of Recent Studies

Viruses ◽  
2021 ◽  
Vol 13 (6) ◽  
pp. 1145
Author(s):  
Hakimeh Baghaei Daemi ◽  
Muhammad Fakhar-e-Alam Kulyar ◽  
Xinlin He ◽  
Chengfei Li ◽  
Morteza Karimpour ◽  
...  
Keyword(s):  
Influenza A ◽  
H1n1 Virus ◽  
World Health ◽  
H1n1 Pandemic ◽  
Global Pandemic ◽  
First Case ◽  
Influenza A H1n1 ◽  
The World ◽  
Novel Coronavirus ◽  
Health Organization

Influenza is a highly known contagious viral infection that has been responsible for the death of many people in history with pandemics. These pandemics have been occurring every 10 to 30 years in the last century. The most recent global pandemic prior to COVID-19 was the 2009 influenza A (H1N1) pandemic. A decade ago, the H1N1 virus caused 12,500 deaths in just 19 months globally. Now, again, the world has been challenged with another pandemic. Since December 2019, the first case of a novel coronavirus (COVID-19) infection was detected in Wuhan. This infection has risen rapidly throughout the world; even the World Health Organization (WHO) announced COVID-19 as a worldwide emergency to ensure human health and public safety. This review article aims to discuss important issues relating to COVID-19, including clinical, epidemiological, and pathological features of COVID-19 and recent progress in diagnosis and treatment approaches for the COVID-19 infection. We also highlight key similarities and differences between COVID-19 and influenza A to ensure the theoretical and practical details of COVID-19.

scholarly journals P2-429 Prevalence of influenza A (H1N1) seropositivity in unvaccinated healthcare workers in Scotland at the height of the global pandemic

2011 ◽  
Vol 65 (Suppl 1) ◽  
pp. A340-A340
Author(s):  
K. Smith ◽  
L. Williams ◽  
W. Adamson ◽  
S. V. Katikireddi ◽  
P. Dewart ◽  
...  
Keyword(s):  
Healthcare Workers ◽  
Influenza A ◽  
Global Pandemic ◽  
Influenza A H1n1

scholarly journals Prevalence of Influenza A (H1N1) Seropositivity in Unvaccinated Healthcare Workers in Scotland at the Height of the Global Pandemic

2011 ◽  
Vol 2011 ◽  
pp. 1-5 ◽  
Author(s):  
Kate Smith ◽  
Pamela Warner ◽  
Linda J. Williams ◽  
Walt E. Adamson ◽  
S. Vittal Katikireddi ◽  
...  
Keyword(s):  
Healthcare Workers ◽  
Influenza A ◽  
Great Majority ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Percentage Points ◽  
Global Pandemic ◽  
Influenza A H1n1 ◽  
The Uk

Background. We set out to identify the level of previous exposure to influenza A (H1N1) in unvaccinated healthcare workers (HCWs) at the peak of the pandemic outbreak in the UK, with control samples collected prior to the outbreak.Methods. Cross-sectional study (seroprevalence assessed before and at pandemic peak, with questionnaire data collected at peak of outbreak) in HCWs in Scotland.Results. The prevalence of seropositivity in 493 HCWs at pandemic peak was 10.3%, which was higher than the prepandemic level by 3.7 percentage points (95% CI 0.3% to 7.3%,P=0.048). Seropositivity rates for frontline and nonfrontline HCWs were similar.Conclusion. At pandemic peak, only 10.3% of HCWs were seropositive for influenza A (H1N1), so the great majority were still susceptible to infection at the introduction of the vaccination programme. Few studies have reported on seroprevalence in unvaccinated and asymptomatic participants, so our findings may have relevance to the wider population.

Nachweis bakterieller Superinfektionen bei Patienten mit Influenza A H1N1 mithilfe kultur-unabhängiger molekulargenetischer Typisierung

2010 ◽  
Vol 222 (S 01) ◽  
Author(s):  
M Schiller ◽  
S Eva ◽  
A Halfmann ◽  
HJ Schäfers ◽  
B Gärtner ◽  
...  
Keyword(s):  
Influenza A ◽  
Influenza A H1n1

Narkolepsie nach Impfung gegen die pandemische Influenza A/H1N1/v?

Schlaf ◽  
2013 ◽  
Vol 2 (03) ◽  
pp. 154-160
Author(s):  
Geert Mayer ◽  
Brigitte Keller-Stanislawski ◽  
Doris Oberle
Keyword(s):  
Influenza A ◽  
Influenza A H1n1

Im Herbst/Winter 2009/2010 wurden etwa 30,8 Mio. Menschen in der Europäischen Union mit Pandemrix® gegen die pandemische Influenza A/H1N1/v geimpft. Der von GlaxoSmithKline produzierte Impfstoff war im September 2009 von der Europäischen Kommission als Pandemieimpfstoff zugelassen worden. Im Sommer 2010 wurde erstmals über Fälle einer Narkolepsie bei Kindern und Jugendlichen nach Impfung mit Pandemrix® in Schweden und Finnland berichtet.

Sign in / Sign up

Export Citation Format

Share Document